BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29305275)

  • 21. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review.
    Smith ER; Scott RM
    J Neurosurg Pediatr; 2012 Apr; 9(4):353-60. PubMed ID: 22462697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult moyamoya disease in an urban center in the United States is associated with a high burden of watershed ischemia.
    Zafar SF; Bershad EM; Gildersleeve KL; Newmark ME; Calvillo E; Suarez JI; Venkatasubba Rao CP
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and clinical features of moyamoya disease in the USA.
    Kainth D; Chaudhry SA; Kainth H; Suri FK; Qureshi AI
    Neuroepidemiology; 2013; 40(4):282-7. PubMed ID: 23445954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological features of moyamoya disease in Japan.
    Hoshino H; Izawa Y; Suzuki N;
    Neurol Med Chir (Tokyo); 2012; 52(5):295-8. PubMed ID: 22688065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moyamoya disease: an elusive diagnosis.
    Asumal KB; Akhtar N; Syed NA; Shafqat S; Baig SM
    J Pak Med Assoc; 2003 Apr; 53(4):160-2. PubMed ID: 12776902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial hemorrhage from moyamoya disease during pregnancy and puerperium.
    Liu XJ; Zhang D; Wang S; Zhao YL; Ye X; Rong W; Yong C; Kang S; Zhao JZ
    Int J Gynaecol Obstet; 2014 May; 125(2):150-3. PubMed ID: 24552854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients.
    Nagata S; Matsushima T; Morioka T; Matsukado K; Mihara F; Sasaki T; Fukui M
    Neurosurgery; 2006 Oct; 59(4):830-6; discussion 836-7. PubMed ID: 17038947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between thyroid autoantibodies in serum and abnormal function and structure of the thyroid.
    Yan YR; Gao XL; Zeng J; Liu Y; Lv QG; Jiang J; Huang H; Tong NW
    J Int Med Res; 2015 Jun; 43(3):412-23. PubMed ID: 25855591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid disease.
    Hiruma M; Watanabe N; Mitsumatsu T; Suzuki N; Fukushita M; Matsumoto M; Yoshihara A; Yoshimura Noh J; Sugino K; Ito K
    Endocr J; 2023 Feb; 70(2):141-148. PubMed ID: 36198616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of Conservative Follow-up or Surgical Treatment of Moyamoya Patients Who Present without Hemorrhage, Transient Ischemic Attack, or Stroke.
    Luo R; Gao F; Deng X; Zhang D; Zhang Y
    World Neurosurg; 2017 Dec; 108():683-689. PubMed ID: 28927919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moyamoya disease and moyamoya syndrome.
    Scott RM; Smith ER
    N Engl J Med; 2009 Mar; 360(12):1226-37. PubMed ID: 19297575
    [No Abstract]   [Full Text] [Related]  

  • 37. Ischemic stroke in a postpartum patient: understanding the epidemiology, pathogenesis, and outcome of Moyamoya disease.
    Ishimori ML; Cohen SN; Hallegua DS; Moser FG; Weisman MH
    Semin Arthritis Rheum; 2006 Feb; 35(4):250-9. PubMed ID: 16461070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
    Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
    J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.